Cart
sales@molnova.com
Brilliant Yellow
CAS No. 3051-11-4
Brilliant Yellow( —— )
Catalog No. M37162 CAS No. 3051-11-4
Brilliant Yellow (Direct Yellow 4) is a potent and selective VGLUT inhibitor, a dye that is photodegradable.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameBrilliant Yellow
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrilliant Yellow (Direct Yellow 4) is a potent and selective VGLUT inhibitor, a dye that is photodegradable.
-
DescriptionBrilliant Yellow, a diazo-containing sulfonic aci, is also a potent VGLUT-specific inhibitor. Brilliant Yellow is membrane-impermeable. However, there are some Brilliant Yellow analogs with low cytotoxicity and cell penetration. Brilliant Yellow analogs work on glutamatergic transmission in hippocampal neurons.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptortransporter
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3051-11-4
-
Formula Weight624.55
-
Molecular FormulaC26H18N4Na2O8S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (16.01 mM; Ultrasonic (<60°C)
-
SMILESO=S([O-])(C1=CC(N=NC2=CC=C(C=C2)O)=CC=C1C=CC3=CC=C(C=C3S(=O)([O-])=O)N=NC4=CC=C(C=C4)O)=O.[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kehrl J, et al. Vesicular Glutamate Transporter Inhibitors: Structurally Modified Brilliant Yellow Analogs. Neurochem Res. 2017 Jun;42(6):1823-1832. ?
molnova catalog
related products
-
MRS 2578
MRS2578, an effective P2Y6 receptor antagonist with IC50 of 37 nM, shows insignificant inhibition at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.
-
Hydroquinine
Hydroquinine is an organic compound and as a cinchona alkaloid closely related to quinine.
-
Diroximel Fumarete
Diroximel fumarate, a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body.
